Matches in Nanopublications for { ?s ?p "[In this study six patients with hormone-refractory prostate cancer were monitored for their ability to mount PSA-specific cellular responses after receiving a pVAX/PSA DNA vaccine (patients 1-3, 100 microg; patients 7-9, 900 microg) with recombinant GM-CSF and IL-2 as adjuvants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP698867.RAmy__f284gwaiHuGzehdUHBXTL-WP60mogjgMeo8x0I8130_assertion description "[In this study six patients with hormone-refractory prostate cancer were monitored for their ability to mount PSA-specific cellular responses after receiving a pVAX/PSA DNA vaccine (patients 1-3, 100 microg; patients 7-9, 900 microg) with recombinant GM-CSF and IL-2 as adjuvants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698867.RAmy__f284gwaiHuGzehdUHBXTL-WP60mogjgMeo8x0I8130_provenance.
- NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_assertion description "[In this study six patients with hormone-refractory prostate cancer were monitored for their ability to mount PSA-specific cellular responses after receiving a pVAX/PSA DNA vaccine (patients 1-3, 100 microg; patients 7-9, 900 microg) with recombinant GM-CSF and IL-2 as adjuvants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_provenance.
- NP720080.RALnF5T8hArLJX_IyW2HKwiq85yvs76BDhefDFmUillUs130_assertion description "[In this study six patients with hormone-refractory prostate cancer were monitored for their ability to mount PSA-specific cellular responses after receiving a pVAX/PSA DNA vaccine (patients 1-3, 100 microg; patients 7-9, 900 microg) with recombinant GM-CSF and IL-2 as adjuvants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720080.RALnF5T8hArLJX_IyW2HKwiq85yvs76BDhefDFmUillUs130_provenance.
- NP850253.RAMg60idP5De5r1soXdVBGKovhCQOrw1uIyod55Id5sig130_assertion description "[In this study six patients with hormone-refractory prostate cancer were monitored for their ability to mount PSA-specific cellular responses after receiving a pVAX/PSA DNA vaccine (patients 1-3, 100 microg; patients 7-9, 900 microg) with recombinant GM-CSF and IL-2 as adjuvants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850253.RAMg60idP5De5r1soXdVBGKovhCQOrw1uIyod55Id5sig130_provenance.